Supported by Randox, Barry Douglas and Camerata Ireland a roaring success as they perform in India’s National Centre for Performing Arts

Supported by Randox, Barry Douglas and Camerata Ireland a roaring success as they perform in India’s National Centre for Performing Arts

Supported by Global Sponsor Randox Laboratories, internationally renowned pianist and Gold Medal winner at the Tchaikovsky International Piano Competition Barry Douglas returned to India last night with Camerata Ireland. Barry founded Camerata Ireland in 1999 with a vision to create a chamber orchestra of excellence to match the best in the world. Since its formation the group has travelled the world to wide critical acclaim.

Over Tuesday 24th and Wednesday 25th April 2018, Camerata Ireland and Barry Douglas performed all five of Beethoven’s piano concertos with Douglas as pianist and conductor to wide critical acclaim. Taking place in the National Centre for the Performing Arts in Mumbai, the concerts marked Randox Laboratories’ commitment to the Indian market and supported the continued development of their manufacturing and R&D facilities in Bangalore.

Managing Director of Randox Laboratories, Dr Peter FitzGerald, commented;

Randox, now celebrating over 36 years of innovation in healthcare diagnostics, is proud of its association with Barry Douglas & Camerata Ireland. As global sponsors we salute this all-Ireland organisation which has a tremendous international reputation, provides world class performances, commits to the development and improvement of the next generation and brings true energy and innovation to their field.

We at Randox truly value this partnership with Barry Douglas & Camerata Ireland as, in our field of endeavour, we strive to improve healthcare and extend life across the globe. Our energies and skills are focused upon the development and provision of world-leading Research and Development in heath diagnostics. We are passionate about what we do and are committed to better healthcare for all which not only improves global healthcare but will significantly extend lives. We believe that innovative diagnostics, with increasingly preventative capabilities, hold the key to improved healthcare for the future.

Randox has four key international sites – in Antrim, Northern Ireland; Dungloe, Ireland; West Virginia in the US and Bangalore, India. Based among other high-tech industries in the capital of the Indian state of Karnataka, Randox’s base in India is a hub for not only world-leading diagnostic research, but also a base for the many Randox sales, logistics, administration and finance teams who service the Indian market.

Barry Douglas, founder of Camerata Ireland, also commented on the historic trip;

“I’m thrilled to be back in India and to be able to bring Camerata Ireland with me. Music connects us all universally and transcends gender, nationality, race and orientation. We are excited to bring our own special taste of Ireland to India and be able to share in this experience with Randox Laboratories, who continue to help the growth and development of our orchestra. We couldn’t have achieved our internationally-acclaimed reputation without them.”

Paul Turnbull, Global Business Manager at Randox, said of the company’s continued investment in the Indian market;

“Randox have been providing the highest quality In-Vitro Diagnostic products into the Indian market for over 20 years. As a business we are very excited about the next 12 months in particular as our business continues to expand and we invest in growing the team at our India base. We continue to build on our world-leading International EQA scheme RIQAS, our niche and high performance reagents, and over the coming months we will be adding revolutionary molecular diagnostic products to our portfolio. Randox continues to lead global diagnostic innovation in one of the world’s fastest growing and most quality-conscious markets.”

    For more information on Barry Douglas and Camerata Ireland please contact the Randox PR team at RandoxPR@randox.com

     

     

    [mpc_cubebox transition_duration=”500″ front_background_color=”#f29760″ side_background_color=”#88d482″ mpc_ribbon__font_preset=”mpc_preset_101″ mpc_ribbon__text=”RX series 123″][mpc_cubebox_side title=”Front” tab_id=”1523963345262-7″][/mpc_cubebox_side][mpc_cubebox_side title=”Side” tab_id=”1523963345448-10″][/mpc_cubebox_side][/mpc_cubebox]


    Clinical Laboratory Survey